Broadcom Introduces First Commercial PON OLT Silicon for

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Broadcom Introduces First Commercial PON OLT Silicon for XGS-PON and NGPON-2 Protocols

LONDON, Oct. 17, 2016 (GLOBE NEWSWIRE) -- Broadband World Forum 2016 - Broadcom Ltd (NASDAQ:AVGO), a global innovation leader in semiconductor solutions for wired and wireless communications, today introduced the industry's first commercially-available PON OLT devices with support for the recently ratified ITU G.9807.1 XGS-PON and G.989 NGPON-2 protocols. By adding support for these critical new protocols, operators will enjoy the benefits of an open, commercial solution, speeding time to market for symmetric 10Gbps broadband services.

Broadcom's BCM68620 is the first commercially-available OLT silicon for the recently ratified ITU G.9807.1 XGS-PON protocol, and will offer the industry's first support for the ITU G.989 NGPON-2 protocol. Including its additional support for the widely-deployed G.984 2 GPON and IEEE 802.3ah 1G EPON, as well as the IEEE 802.3av 10G EPON protocol, the BCM68620 is the most comprehensive PON OLT development platform on the market today.

Broadcom's multi-mode BCM68620 system-on-a-chip (SoC) integrates support for both existing and next-generation fiber technologies1 under a common application programming interface (API), to enable a unified system software design that can be applied to all PON protocols supported by a system manufacturer. The new support for XGS-PON and NGPON2 fall under this same API umbrella, offering excellent software re-use to existing BCM68620 customers as they easily expand their PON portfolio with line cards dedicated to these new protocols.

“Broadcom heard operators’ need for support of the new XGS-PON and NGPON2 standards in commercial silicon, and OEM requirements for simplified development, and we responded,” said Greg Fischer, senior vice president and general manager, Broadband Carrier Access, Broadcom. “Built on our proven PON OLT technologies, the updated BCM68620 family offers the industry’s only silicon platform with support for all the PON protocols ratified and shipping in volume by operators worldwide.”

“We are encouraged by Broadcom's aggressive investment in next-generation PON technologies," said Dr. Shen Chengbin, senior director, Shanghai Research Institute at China Telecom Corporation Limited. “With early support for the new XGS-PON protocol, Broadcom is providing us with an opportunity to deliver exciting new services to the China market.”

In combination with the new BCM68580 10Gigabit PON ONU solutions, also supporting XGS-PON and NGPON2, Broadcom is now the only vendor with an end-to-end commercial solution for all commercially viable PON technologies.

Key Features of the BCM68620 SoC

  • First commercially-available PON OLT solution for the new XGS-PON and NGPON2 protocols
  • Broadcom-designed, high-performance PON and 10G-PON burst-mode SerDes
  • Integrated SerDes for glue-less chip-to-chip or backplane (10GKR) interconnect
  • High-performance embedded engines for dynamic bandwidth allocation and device management

Availability
Broadcom's BCM68620 family is currently sampling. Broadcom will be demonstrating the solution at Broadband World Forum in London, October 18-20, 2016, Meeting Room #36.

Resources
1 Next-generation technologies include EPON, GPON, XGPON1, XGS-PON, NGPON2 and 10G EPON

About Broadcom Limited
Broadcom Limited (NASDAQ:AVGO) is a leading designer, developer and global supplier of a broad range of analog and digital semiconductor connectivity solutions.  Broadcom Limited’s extensive product portfolio serves four primary end markets:  wired infrastructure, wireless communications, enterprise storage and industrial & other. Applications for our products in these end markets include: data center networking, home connectivity, broadband access, telecommunications equipment, smartphones and base stations, data center servers and storage, factory automation, power generation and alternative energy systems, and displays.  For more information, go to www.broadcom.com.

Broadcom, the pulse logo, Connecting everything, and Avago Technologies are among the trademarks of Broadcom.  The term "Broadcom" refers to Broadcom Limited and/or its subsidiaries.

Press Contact: David Szabados Corporate Communications david.szabados@broadcom.com Telephone: 1-408-433-7848

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 39

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 46

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 48

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 44

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 50

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 61

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 58

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading

Top 5 Most Recently Viewed Articles

Cemtrex's Stock Surge Sparks Interest in Leading Movers

Updated Category News Views 117

Cemtrex Experiences Notable Share Surge Shares of Cemtrex, Inc. CETX have seen a significant uptick amid pre-market trading. This boost comes on the heels of better-than-expected sales in the latest quarter, reporting an impressive $18.10 million in sales, surpassing the general analyst expectation of $16.39 million. This remarkable performance in sales has sparked...

Continue Reading
Exciting New PharmD-MBA Pathway Combines Pharmacy and Business

Updated Category News Views 193

Collaboration between Cal Poly Pomona and Western University In an exciting move, Cal Poly Pomona's Singelyn Graduate School of Business and Western University of Health Sciences have teamed up to create a groundbreaking pathway for aspiring healthcare professionals. This innovative PharmD-MBA program combines the fields of pharmacy and business, providing a unique...

Continue Reading
Kaskela Law Investigates Stock Misconduct in Stanley Black & Decker

Updated Category News Views 155

Overview of the Investigation by Kaskela Law LLC Kaskela Law LLC has announced an important investigation focused on Stanley Black & Decker, Inc. (NYSE: SWK) concerning allegations of potential securities fraud. This inquiry is primarily aimed at safeguarding the interests of long-term investors who hold shares in this well-known manufacturing company. Details Surrounding...

Continue Reading
Legend Biotech's Carvykti: A Leading Force in Cancer Treatment

Updated Category News Views 90

Redburn's Positive Outlook for Legend Biotech Recently, Redburn-Atlantic began covering Legend Biotech Corp. (NASDAQ: LEGN) with a favorable Buy rating and set a price target of $86.00 for the stock. This biotechnology company has made significant strides, particularly with the recent approval of its innovative product, Carvykti, designed for the treatment of multiple...

Continue Reading
Transforming the Anti-Obesity Drug Market for Future Success

Updated Category News Views 132

Global Anti-Obesity Drug Market Overview As global health concerns rise, the demand for anti-obesity drugs is surging. Recent reports estimate that the anti-obesity drug market will soar to USD 82.55 billion in the coming years. This impressive growth, fueled by an anticipated compound annual growth rate (CAGR) of 18.01%, signals a crucial moment for pharmaceutical...

Continue Reading